(Q22241907)

English

Diagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria

scientific article published on August 1, 1997

Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Diagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria (English)

0 references

Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9279284

14 November 2024

0 references

language of work or name

0 references

publication date

August 1997

0 references

full work available at URL

http://ajrccm.atsjournals.org/cgi/content/abstract/156/2/S1

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9279284

14 November 2024

https://www.atsjournals.org/doi/pdf/10.1164/ajrccm.156.2.atsstatement

1 reference

10.1164/AJRCCM.156.2.ATSSTATEMENT

https://api.crossref.org/works/10.1164/AJRCCM.156.2.ATSSTATEMENT

14 November 2024

American Journal of Respiratory and Critical Care Medicine

0 references

156

0 references

2

0 references

S1-S25

0 references

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Mycobacteria in water

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Mycobacterium marinum infections in man

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

The isolation of M. kansasii and M. xenopi from water systems

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Two Outbreaks of Sternal Wound Infections Due to Organisms of the Mycobacterium fortuitum Complex

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Mycobacterium chelonaeCausing Otitis Media in an Ear-Nose-and-Throat Practice

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Nosocomial Mycobacterium fortuitum colonization from a contaminated ice machine

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Outbreak of Mycobacterium chelonae Infection Associated With Use of Jet Injectors

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Bronchoscopy-associated Mycobacterium xenopi pseudoinfections

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Isolation of Mycobacterium simiae from clinical specimens in Israel.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Clinical isolates of Mycobacterium simiae in San Antonio, Texas. An 11-yr review

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Epidemiology of mycobacterial diseases

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Isolation of Mycobacterium malmoense from the environment in Zaire

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Mycobacterium genavense: An emerging pathogen

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

An epidemiologic analysis of Mycobacterium avium complex disease in homosexual men infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Mycobacterium avium complex infection in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Mycobacterium haemophilum: An emerging pathogen

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Mycobacterium celatum sp. nov

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Efficacy of trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus: a report from Tunisia

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Mycobacterium simiae infection in Israeli patients with AIDS

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Infection with Mycobacterium avium complex in patients without predisposing conditions

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Management of atypical mycobacterial lymphadenitis in childhood: A review based on 380 cases

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long-term follow-up

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Mycobacterium haemophilum causing perihilar or cervical lymphadenitis in healthy children

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Mycobacterial cervical lymphadenopathy. Relation of etiologic agents to age.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Extrapulmonary and disseminated infections due to Mycobacterium malmoense: case report and review

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Bacteriologically confirmed non-tuberculous mycobacterial lymphadenitis in south east England: a recent increase in the number of cases

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Localized Soft-Tissue Infections with Mycobacterium avium/Mycobacterium intracellulare Complex in Immunocompetent Patients: Granulomatous Tenosynovitis of the Hand or Wrist

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Mycobacterium chelonae: a cause of nodular skin lesions with a proclivity for renal transplant recipients

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Disseminated infection with rapidly growing mycobacteria

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methods

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Mycobacteria and the new quinolones

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

In vitro activity of clofazimine against rapidly growing nonchromogenic mycobacteria

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Pulmonary infection with mycobacterium xenopi: review of treatment and response

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Mycobacterium avium complex pulmonary disease. Incidence, presentation, and response to therapy in a community setting

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents?

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Mycobacterium avium Complex Pulmonary Disease Presenting as an Isolated Lingular or Middle Lobe Pattern

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Clarithromycin in the treatment of Mycobacterium avium lung infections in patients without AIDS. Clarithromycin Study Group of France

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Mycobacterium avium strains resistant to clarithromycin and azithromycin

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study G

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Adverse events associated with high-dose rifabutin in macrolide-containing regimens for the treatment of Mycobacterium avium complex lung disease

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

The impact of Mycobacterium avium complex bacteremia and its treatment on survival of AIDS patients--a prospective study.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Efficacy of rifabutin in the treatment of disseminated infection due to Mycobacterium avium complex. The Rifabutin Treatment Group.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Human disease due to Mycobacterium smegmatis.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Bacteremia caused by a previously unidentified species of rapidly growing Mycobacterium successfully treated with vancomycin

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

The successful treatment of tropical fish tank granuloma (Mycobacterium marinum) with co-trimoxazole

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Pulmonary infection with Mycobacterium malmoense--a review of treatment and response

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

The nature of mycobacterial disease in south east England, 1977-84.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

21 January 2018

Letter: Tetracycline therapy for atypical mycobacterial granuloma

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Cervical mycobacterial lymphadenitis. Medical vs surgical management

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined use of fine-needle aspiration cytologic examination and tuberculin skin test in the diagnosis of cervical tuberculous lymphadenitis. A prospective study

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Nontuberculous mycobacterial infections of the head and neck

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic lymphadenopathy due to mycobacterial infection. Clinical features, diagnosis, histopathology, and management.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulmonary disease in adults associated with unclassified mycobacteria

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of medical treatment in Mycobacterium intracellulare infection

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycobacterium fortuitum bacteremia in patients with cancer and long-term venous catheters

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Disseminated Mycobacterium fortuitum disease in an AIDS patient

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical management of resistant mycobacterial tuberculosis and other mycobacterial pulmonary infections

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Post-surgical outcome of 57 patients with Mycobacterium xenopi pulmonary infection

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of the BACTEC system for drug susceptibility testing of Mycobacterium tuberculosis, M. kansasii, and M. avium complex

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Amikacin, ethambutol, and rifampin for treatment of disseminated Mycobacterium avium-intracellulare infections in patients with acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of pulmonary resection for atypical mycobacterial disease

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. MAC Study Group of the Canadian HIV Trials Network

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Infection with Mycobacterium malmoense in Sweden: report of 221 cases

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Rifampin-resistant Mycobacterium kansasii

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Dual skin testing with Mycobacterium avium sensitin and purified protein derivative: an open study of patients with M. avium complex infection or tuberculosis.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Clarithromycin-induced hepatotoxicity

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulmonary disease due to infection by Mycobacterium avium complex in patients with AIDS

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for Pulmonary Disease Due to Mycobacterium kansasii: Efficacies of Some Individual Drugs

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of Pulmonary Disease Due to Mycobacterium kansasii: Recent Experience with Rifampin

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of Disease Due to Mycobacterium intracellulare

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical Management of Pulmonary Disease Due to Mycobacterium avium-intracellulare

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical Usefulness of Amikacin and Doxycycline in the Treatment of Infection Due to Mycobacterium fortuitum and Mycobacterium chelonei

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

In Vitro and In Vivo Susceptibility of Atypical Mycobacteria to Various Drugs

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Recent Experience in the Epidemiology of Disease Caused by Atypical Mycobacteria

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycobacterial Infections in Renal Transplant Recipients: Report of Five Cases and Review of the Literature

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Infections caused by Mycobacterium szulgai in humans.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Peritonitis due to a mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolation of nontuberculous mycobacteria in the United States, 1980

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Infection due to organisms of the Mycobacterium fortuitum complex after augmentation mammaplasty: clinical and epidemiologic features

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Infections with Mycobacterium chelonei in patients receiving dialysis and using processed hemodialyzers

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasmid DNA profiles as epidemiological markers for clinical and environmental isolates of Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Diversity and sources of rapidly growing mycobacteria associated with infections following cardiac surgery

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycobacterium abscessus pseudoinfection traced to an automated endoscope washer: utility of epidemiologic and laboratory investigation

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol, and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDS

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Disseminated infection with Mycobacterium avium-intracellulare. A report of 13 cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Usefulness of skin testing with mycobacterial antigens in children with cervical lymphadenopathy

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Disseminated Mycobacterium avium complex in non-human immunodeficiency virus-infected pediatric patients

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycobacterium avium complex parotid lymphadenitis: successful therapy with clarithromycin and ethambutol

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycobacterium malmoense isolated from soil

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibility testing of Mycobacterium avium complex isolates

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Environmental factors affecting the occurrence of mycobacteria in brook waters.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology of infection by nontuberculous mycobacteria

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of a simple method for growing Mycobacterium haemophilum

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

The resurgence of tuberculosis: is your laboratory ready?

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Current practices in mycobacteriology: results of a survey of state public health laboratories

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycobacterium conspicuum sp. nov., a new species isolated from patients with disseminated infections

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of Mycobacterium tuberculosis and M. avium complex directly from smear-positive sputum specimens and BACTEC 12B cultures by high-performance liquid chromatography with fluorescence detection and computer-driven pattern recognition mod

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective utilization of DNA probes for identification of Mycobacterium species on the basis of cord formation in primary BACTEC 12B cultures

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Algorithm for use of nucleic acid probes for identifying Mycobacterium tuberculosis from BACTEC 12B bottles

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Genotypic characterization of five subspecies of Mycobacterium kansasii

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Research Committee, British Thoracic Society

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycobacterium avium-intracellulare complex: evaluation with CT

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Atypical mycobacterial infection in the lung: CT appearance

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulmonary tuberculosis and Mycobacterium avium-intracellulare: a comparison of CT findings

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

American Thoracic Society. Diagnostic standards and classification of tuberculosis

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnosis and treatment of disease caused by nontuberculous mycobacteria

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycobacterium simiae. Clinical features and follow-up of twenty-four patients

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence of Buruli ulcer disease in the Daloa region of Cote d'Ivoire.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Disseminated infection with Mycobacterium kansasii in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycobacterium xenopi Infections in the Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinical study of the chronic lung disease due to nonphotochromogenic acid-fast bacilli

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.2.ATSSTATEMENT

7 January 2021

based on heuristic

inferred from DOI database lookup

American review of tuberculosis

39

75

199

author name string

Crow H. E.

publication date

1957

1 reference

10.1164/AJRCCM.156.2.ATSSTATEMENT

https://api.crossref.org/works/10.1164/AJRCCM.156.2.ATSSTATEMENT

14 November 2024

Spectrum of Disease Due to Rapidly Growing Mycobacteria

87

1 reference

10.1164/AJRCCM.156.2.ATSSTATEMENT

https://api.crossref.org/works/10.1164/AJRCCM.156.2.ATSSTATEMENT

14 November 2024

Laboratory aspects of "Mycobacterium genavense," a proposed species isolated from AIDS patients

105

1 reference

10.1164/AJRCCM.156.2.ATSSTATEMENT

https://api.crossref.org/works/10.1164/AJRCCM.156.2.ATSSTATEMENT

14 November 2024

Mycobacterium thermoresistibile: a new pathogen for humans

184

1 reference

10.1164/AJRCCM.156.2.ATSSTATEMENT

https://api.crossref.org/works/10.1164/AJRCCM.156.2.ATSSTATEMENT

14 November 2024

Identifiers

10.1164/AJRCCM.156.2.ATSSTATEMENT

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q22241907&oldid=2274392290"